Aptalis Pharmaceutical Technologies has released two new free-to-download white papers on Pharmaceutical Technology.
In the first, ‘Targeting PK and Patient Needs with Versatile, Time-Based Oral Drug Delivery’, Aptalis explores the growing trend among pharmaceutical developers of repositioning existing products across multiple indications, developing alternative dosage forms, or reformulating them to modify pharmacokinetic profiles.
The second white paper, ‘Growing from a Broader Base’, is an article first published by scrip100.com in which Aptalis president John Fraher discusses the direction of his newly enlarged company, formed in 2011 through the merger of Axcan and Eurand.